New Cancer Drug Shrinks Tumors in 62% of Lung Cancer Patients

A promising new pill shrank tumors in nearly two-thirds of lung cancer patients and 40% of pancreatic cancer patients in early trials.

The results exceeded expectations and could offer fresh hope for people facing these difficult diagnoses.